The data highlight the possibility of SGLT 1/2 inhibitors having protective effects beyond heart failure and diabetes.
It comes as a study found fewer than 18% of people in England have been treated with the most suitable blood sugar lowering ...
New figures show fewer than one in five people with the condition in England are on the best medication for them to manage ...
A recent study published in the Journal of the American College of Cardiology found that high plasma lipoproteins can cause chronic kidney disease by impairing kidney function. Chronic ...
11h
For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with ...
The prevalence of type 2 diabetes is rising globally, with a disproportionate impact on individuals in low-income and middle-income countries, where access to care and new therapies is often limited.
GLP-1RA discontinuation and lack of reinitiation was more common among patients with obesity and without type 2 diabetes than with type 2 diabetes.
The following is a summary of “Glycemic and weight control in people with type 2 diabetes: A real-world observational study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback